About
Quercis develops investigational oral therapies targeting thrombo-inflammation related to cancer and virally induced thrombosis, advancing treatments through clinical phases including Phase 3 trials.
Explore Quercis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.